These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35250225)

  • 41. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.
    Gadbail AR; Chaudhary M; Sarode SC; Gondivkar S; Tekade SA; Zade P; Hande A; Sarode GS; Patil S
    PLoS One; 2018; 13(7):e0200171. PubMed ID: 30001387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
    Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
    J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.
    Saran G; Umapathy D; Misra N; Channaiah SG; Singh P; Srivastava S; Shivakumar S
    Indian J Dent Res; 2018; 29(3):303-312. PubMed ID: 29900913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of myofibroblasts in oral submucous fibrosis: correlation with disease severity.
    Angadi PV; Kale AD; Hallikerimath S
    J Oral Pathol Med; 2011 Mar; 40(3):208-13. PubMed ID: 21198872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A potential new oral mapping (OM) method in the clinical evaluation and documentation of oral submucous fibrosis-A prospective clinical crossover study.
    Arakeri G; Aljabab A; Maddur N; Hunasgi S; Patil S; Hale B; Merkx MAW; Gomes CC; Gomez RS; Brennan PA
    J Oral Pathol Med; 2019 Apr; 48(4):315-320. PubMed ID: 30604897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis.
    Anura A; Das RK; Pal M; Paul RR; Ray AK; Chatterjee J
    Pathol Res Pract; 2014 Dec; 210(12):1054-63. PubMed ID: 25015036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral submucous fibrosis: two cases of malignant transformation in Asian immigrants to the United Kingdom.
    McGurk M; Craig GT
    Br J Oral Maxillofac Surg; 1984 Feb; 22(1):56-64. PubMed ID: 6582933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spirulina and pentoxyfilline - a novel approach for treatment of oral submucous fibrosis.
    Mulk BS; Deshpande P; Velpula N; Chappidi V; Chintamaneni RL; Goyal S
    J Clin Diagn Res; 2013 Dec; 7(12):3048-50. PubMed ID: 24551724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral submucous fibrosis in a 12-year-old Bangladeshi boy: a case report and review of literature.
    Yusuf H; Yong SL
    Int J Paediatr Dent; 2002 Jul; 12(4):271-6. PubMed ID: 12121538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral submucous fibrosis in a school-going Indian adolescent boy.
    Khandelwal V; Kambalimath HV; Reddy NB; Khandelwal S; Reddy V; Gupta N
    Int J Adolesc Med Health; 2017 Jul; 30(5):. PubMed ID: 28731854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A light microscopic study of fibrosis involving muscle in oral submucous fibrosis.
    Rooban T; Saraswathi TR; Al Zainab FH; Devi U; Eligabeth J; Ranganathan K
    Indian J Dent Res; 2005; 16(4):131-4. PubMed ID: 16761704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis.
    Sarode SC; Sarode GS
    Med Hypotheses; 2013 Oct; 81(4):540-3. PubMed ID: 23891040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between thickness of fibrosis and epithelial dysplasia in oral submucous fibrosis.
    Jayasooriya PR; Nadeeka Jayasinghe KA; Mudiyanselage Tilakaratne W
    J Investig Clin Dent; 2011 Aug; 2(3):171-5. PubMed ID: 25426787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis.
    Pandya S; Chaudhary AK; Singh M; Singh M; Mehrotra R
    Head Neck Oncol; 2009 May; 1():10. PubMed ID: 19409103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral Submucous Fibrosis: Correlation of Clinical Grading to Various Habit Factors.
    Jha VK; Kandula S; Ningappa Chinnannavar S; Rout P; Mishra S; Bajoria AA
    J Int Soc Prev Community Dent; 2019; 9(4):363-371. PubMed ID: 31516870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and Safety of Intralesional Xantinol Nicotinate in the Treatment of Various Stages of Oral Submucous Fibrosis.
    Singh U
    J Clin Diagn Res; 2016 Oct; 10(10):ZC34-ZC37. PubMed ID: 27891454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of ultrasonographic measurements, histopathological grading, and clinical staging in oral submucous fibrosis.
    Agarwal RK; Hebbale M; Mhapuskar A; Tepan M
    Indian J Dent Res; 2017; 28(5):476-481. PubMed ID: 29072206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total Serum Protein Estimation and Its Correlation with Clinical and Histopathological Grading using Masson's Trichrome Stain in Patients of Oral Submucous Fibrosis.
    Sannad A; Tamgadge S; Tamgadge A; Yadav KS; Giri A; Wankhede M
    Contemp Clin Dent; 2017; 8(2):286-292. PubMed ID: 28839417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients.
    Sivaramakrishnan M; Sivapathasundharam B; Jananni M
    J Oral Pathol Med; 2015 Jul; 44(6):449-52. PubMed ID: 25224513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel mouth-exercising device for oral submucous fibrosis.
    Patil PG; Patil SP
    J Prosthodont; 2012 Oct; 21(7):556-60. PubMed ID: 22779909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.